Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Europe midday: Merck, Airbus lead losses as markets fall

(Sharecast News) - European stocks were firmly lower by the midday mark in Frankfurt as heavy falls in the aerospace and pharmaceuticals sectors weighed on indices across the continent. Big falls from biopharma group Merck and aerospace giant Airbus were weighing heavily on sentiment, while growing uncertainty ahead of this week's elections in France were keeping a lid on risk appetite.

"Coming off the back of a US session that had seen weakness across both the Nasdaq and S&P 500, that same downbeat tone appears to be evident in Europe despite a lack of any particularly notable economic releases this morning," said Joshua Mahony, chief market analyst at IG.

The pan-European Stoxx 600 benchmark index was 0.3% lower by lunchtime. Germany's Dax and France's Cac 40 were the worst performers of the session, down 1% and 0.6% respectively; while markets in the UK, Spain and Italy fell by a lesser amount.

Merck plummeted after the biopharma group called time on a cancer drug trial of lack of efficacy. The company stopped its trial of head and neck cancer treatment xevinapant, marking "another surprising setback for the healthcare pipeline", according to analysts at Barclays.

Airbus was out of favour after cutting its full-year earnings targets as a result of a "degraded operating environment", meaning it would only deliver around 700 aircraft this year, compared with previous guidance of 800. Annual EBITDA is now expected to be €5.5bn, down from earlier guidance of €7bn.

Sentiment in the travel and aerospace sector was also dented by news overnight that a Boeing plane operating a Korean Air flight heading for Taiwan dropped 25,000 feet in five minutes after a fault with its pressurisation system, adding to more woes for the American aircraft manufacturer.

Meanwhile, US prosecutors recommended overnight that the Department of Justice bring criminal charges against Boeing for violating a settlement related to two fatal crashes in 2018 and 2019.

Aerospace and engineering firms were all in the red in Europe, with MTU Aero Engines, Melrose, Rolls-Royce, SAFRAN, Trelleborg and Dassault Aviation all falling sharply.

London's FTSE 100 was outperforming wider European markets, falling by just 0.1% as downside was limited by gains from heavyweights Shell and BP.

Economic data was thin on the ground on Tuesday, with revisions to first-quarter GDP in Spain the only notable release. The economy expanded by 0.8% in the first three months of 2024, up from the initial estimate of 0.7% and the 0.7% growth seen in the fourth quarter - marking the strongest quarterly growth in nearly two years. The annual growth rate was also revised 10 basis points higher to 2.5%.

Share this article

Related Sharecast Articles

London close: Stocks fall on EU inflation, US jobs data
(Sharecast News) - London stocks closed lower on Tuesday as investors digested eurozone inflation data and a modest increase in US job openings.
Europe close: Stocks trim losses across the continent
(Sharecast News) - European markets were in the red on Tuesday after core inflation proved stickier than expected, but stocks rallied into the close with indices finishing well above their intraday lows.
FTSE 250 movers: Real estate stocks up on Tritax Eurobox M&A activity
(Sharecast News) - The FTSE 250 was keeping its head above water on Tuesday despite a wider sell-off across European stock markets with some big names in the real estate and investment sectors were lifted by M&A activity involving Tritax Eurobox.
Broker tips: Bunzl, National Grid, Sainsbury
(Sharecast News) - Analysts at RBC Capital Markets hiked their target price on distribution group Bunzl from 2,600.0p to 2,700.0p on Tuesday following the company's Q2 trading update.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.